Statin Eligibility Prior to Myocardial InfarCtion

NCT03485742 | Terminated DMC

• 1 other identifier: JCCStatinEpic2018
• Study Type: observational
• Target: 740
• Locations: 1 country
• Sites: 5

Brief Summary

The study (Statin Eligibility Prior to myocardial infarction (MI) in Jordanians, StatinEPIC) is

1. 1.Cross sectional
2. 2.Non interventional
3. 3.One encounter per patient. No follow up. It addresses a major issue of primary prevention in Jordanians especially the young population, namely the issue of lipid lowering agents before sustaining an acute MI. A recent study in USA showed that 50% of patients who sustained MI were not eligible to statins had they been evaluated before the heart attack. It is largely unknown if a larger percentage of Middle Eastern patients who sustain a heart attack would be eligible to receive lipid lowering agents.
4. 4.The PI will overlook the whole process. Dr Ahmad Tamari, the assistant to the PI will asses this whole process of data collection, management and manuscript drafting.

Conditions

Statins; Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

• Eligible patients for statin therapy

  The primary outcome is to calculate the percentage of enrolled patients who do meet the AHA/ACC Guidelines for receiving statins as a primary prevention measure.

  Within 24 hour of enrollment

Interventions

No intervention OTHER

No intervention. Collection of data on statin eligibility in patients admitted with MI

Eligibility Criteria

• Age: 30 Years - 75 Years
• Gender Eligibility Details: Male, female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 30 to 75 years admitted with MI (ST elevation and non ST elevation) who are not receiving statins prior to admission will be evaluated for potential eligibility had they been evaluated prior to admission with MI.

You may qualify if:

• Adults admitted with MI, age 30 to 75
• known lipid profile

You may not qualify if:

• on statin before enrollment

Sponsors & Collaborators

• Jordan Collaborating Cardiology Group: lead

Study Sites (5)

Istishari Hospital

Amman, 11184, Jordan

Location

The University of Jordan

Amman, 11942, Jordan

Location

Jordan Hospital

Amman, Jordan

Location

Khalidi Hospital & Medical Center

Amman, Jordan

Location

King Abdullah University Hospital

Irbid, Jordan

Location

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis

Study Officials

• Yasmine Obeidat, MS

  Hashemmeyyeh University School of Medicine, Zarka, Jordan

  STUDY DIRECTOR

• Ayman J Hammoudeh, MD, FACC

  Istishari Hospital, Department of Cardiology, Amman, Jordan

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 17, 2018
• First Posted: April 2, 2018
• Study Start: April 22, 2019
• Primary Completion: June 10, 2019
• Study Completion: June 10, 2019
• Last Updated: June 26, 2019

Record last verified: 2019-06

Data Sharing

• IPD Sharing: Will not share

Locations

JO (5)